- Home
- BEAT vs CIF Comparison
BEAT vs CIF Comparison
Compare BEAT & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- CIF
- Stock Information
- Founded
- BEAT 2015
- CIF 1988
- Country
- BEAT United States
- CIF United States
- Employees
- BEAT N/A
- CIF N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- CIF Trusts Except Educational Religious and Charitable
- Sector
- BEAT Technology
- CIF Finance
- Exchange
- BEAT Nasdaq
- CIF Nasdaq
- Market Cap
- BEAT 33.1M
- CIF 30.8M
- IPO Year
- BEAT 2021
- CIF N/A
- Fundamental
- Price
- BEAT $1.03
- CIF $1.75
- Analyst Decision
- BEAT Buy
- CIF
- Analyst Count
- BEAT 1
- CIF 0
- Target Price
- BEAT $8.00
- CIF N/A
- AVG Volume (30 Days)
- BEAT 118.9K
- CIF 43.9K
- Earning Date
- BEAT 08-13-2025
- CIF 01-01-0001
- Dividend Yield
- BEAT N/A
- CIF 10.11%
- EPS Growth
- BEAT N/A
- CIF N/A
- EPS
- BEAT N/A
- CIF N/A
- Revenue
- BEAT N/A
- CIF N/A
- Revenue This Year
- BEAT N/A
- CIF N/A
- Revenue Next Year
- BEAT N/A
- CIF N/A
- P/E Ratio
- BEAT N/A
- CIF N/A
- Revenue Growth
- BEAT N/A
- CIF N/A
- 52 Week Low
- BEAT $0.91
- CIF $1.47
- 52 Week High
- BEAT $3.48
- CIF $1.77
- Technical
- Relative Strength Index (RSI)
- BEAT 40.15
- CIF 49.44
- Support Level
- BEAT $0.91
- CIF $1.73
- Resistance Level
- BEAT $1.32
- CIF $1.76
- Average True Range (ATR)
- BEAT 0.12
- CIF 0.02
- MACD
- BEAT 0.01
- CIF -0.00
- Stochastic Oscillator
- BEAT 29.27
- CIF 30.00
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.